NCT03677037

Brief Summary

The study will evaluate the benefitial and harmful effects of short-term (20 weeks) compared to long-term (14 months) mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
166

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Sep 2018

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 19, 2018

Completed
5 days until next milestone

Study Start

First participant enrolled

September 24, 2018

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2023

Completed
Last Updated

January 12, 2024

Status Verified

January 1, 2024

Enrollment Period

4.2 years

First QC Date

September 14, 2018

Last Update Submit

January 11, 2024

Conditions

Keywords

mentalization-based therapyborderline personality disorderrandomized clinical trialpsychotherapy researchtreatment intensity

Outcome Measures

Primary Outcomes (1)

  • Change in severity of borderline personality disorder assessed with the Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) interview

    ZAN-BPD is an investigator-administered interview assessing change in severity of borderline personality disorder over time. Each of the nine DSM-5 criteria for borderline personality disorder are rated on a scale from 0-4, where 4 is the most severe, yielding a total score from 0-36.

    Assessed at baseline, and at 8, 16 and 24 months post-randomization

Secondary Outcomes (4)

  • Change in functional impairmment assessed with the Work and Social Adjustment Scale (WSAS)

    Assessed at baseline, and at 8, 16 and 24 months post-randomization

  • Change in quality of life assessed with the Short-Form Health Survey 36 (SF-36)

    Assessed at baseline, and at 8, 16 and 24 months post-randomization

  • Change in global functioning assessed with the Global Assessment of Functioning (GAF)

    Assessed at baseline, and at 8, 16 and 24 months post-randomization

  • Change in amount of self-harm incidents

    Assessed at baseline, and at 8, 16 and 24 months post-randomization

Other Outcomes (1)

  • Change in psychiatric symptom distress assessed with the Symptom Checklist 90 (SCL-90)

    Assessed at baseline, and at 8, 16 and 24 months post-randomization

Study Arms (2)

Short-term MBT

EXPERIMENTAL

The experimental group is short-term mentalization-based therapy. The treatment program includes 20 weeks of mentalization-based group therapy with conjoined individual therapy every second week. The program also includes psychoeducation and individual caseformulations.

Other: Short-term MBT

Long-term MBT

ACTIVE COMPARATOR

The control group is long-term mentalization-based therapy. The treatment program includes 14 months of weekly mentalization-based group therapy with combined individual therapy every second week. The program also includes psychoeducation and individual caseformulations.

Other: Long-term MBT

Interventions

Short-term mentalization-based therapy

Short-term MBT

Long-term mentalization-based therapy

Long-term MBT

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years
  • Personality disorder(s) considered to be primary diagnosis/diagnoses
  • A minimum of four DSM-5 criteria for borderline personality disorder
  • Written informed consent

You may not qualify if:

  • Possibility of a learning disability (IQ\<75)
  • A diagnosis of schizotypal personality disorder or antisocial personality disorder
  • Presence of a comorbid psychiatric disorder that requires specialist treatment elsewhere
  • Current (past 2 months) substance dependance including alcohol
  • Concurrent psychotherapeutic treatment outside the clinic
  • \- Lack of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stolpegaard Psychotherapy Centre, Mental Health Services, Capital Region of Denmark

Gentofte Municipality, 2820, Denmark

Location

Related Publications (5)

  • Juul S, Jakobsen JC, Hestbaek E, Jorgensen CK, Olsen MH, Rishede M, Frandsen FW, Bo S, Lunn S, Poulsen S, Sorensen P, Bateman A, Simonsen S. Short-Term versus Long-Term Mentalization-Based Therapy for Borderline Personality Disorder: A Randomized Clinical Trial (MBT-RCT). Psychother Psychosom. 2023;92(5):329-339. doi: 10.1159/000534289. Epub 2023 Nov 7.

  • Juul S, Simonsen S, Poulsen S, Lunn S, Sorensen P, Bateman A, Jakobsen JC. Detailed statistical analysis plan for the short-term versus long-term mentalisation-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder randomised clinical trial (MBT-RCT). Trials. 2021 Jul 28;22(1):497. doi: 10.1186/s13063-021-05450-y.

  • Gibbon S, Khalifa NR, Cheung NH, Vollm BA, McCarthy L. Psychological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2020 Sep 3;9(9):CD007668. doi: 10.1002/14651858.CD007668.pub3.

  • Storebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.

  • Juul S, Lunn S, Poulsen S, Sorensen P, Salimi M, Jakobsen JC, Bateman A, Simonsen S. Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial. Trials. 2019 Apr 5;20(1):196. doi: 10.1186/s13063-019-3306-7.

MeSH Terms

Conditions

Borderline Personality Disorder

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Study Officials

  • Sebastian Simonsen, PhD

    Sponsor-Investigator

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 14, 2018

First Posted

September 19, 2018

Study Start

September 24, 2018

Primary Completion

December 15, 2022

Study Completion

December 15, 2023

Last Updated

January 12, 2024

Record last verified: 2024-01

Locations